Literature DB >> 19926842

Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study.

Suk Jae Kim1, Kwang Gi Heo, Hee Young Shin, Oh Young Bang, Gyeong-Moon Kim, Chin-Sang Chung, Keon Ha Kim, Pyoung Jeon, Jong Soo Kim, Seung-Chyul Hong, Kwang Ho Lee.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the association between thyroid autoantibodies and moyamoya disease (MMD) in patients with an apparent euthyroid state.
METHODS: We prospectively studied angiographically diagnosed patients with MMD. We compared demographic profiles, thyroid function test, and thyroid autoantibody status between MMD and control groups.
RESULTS: A total of 63 patients with MMD, 71 patients with non-MMD stroke, and 200 healthy control subjects were included. The prevalence of elevated thyroid autoantibodies was higher in the MMD group than in other groups (P<0.01 for MMD versus non-MMD; P<0.001 for MMD versus control subjects). After adjusting for covariates, the elevated thyroid autoantibodies (OR, 4.871; 95% CI, 1.588 to 15.277) and smoking habits (OR, 0.206 for current smoker; 95% CI, 0.054 to 0.786) were independently associated with MMD versus non-MMD stroke.
CONCLUSIONS: Elevated thyroid autoantibodies were frequently observed in patients with MMD. The results of the present study suggest that immune aberrancies associated with or underlying thyroid autoimmunity are also playing a role in developing MMD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926842     DOI: 10.1161/STROKEAHA.109.562264

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  32 in total

1.  Elevated thyroid autoantibodies and intracranial stenosis in stroke at an early age.

Authors:  Zhenghao Shi; Xuting Zhang; Zhicai Chen; David S Liebeskind; Min Lou
Journal:  Int J Stroke       Date:  2013-09-12       Impact factor: 5.266

2.  Moyamoya syndrome associated with Graves' disease: a case series study.

Authors:  Jun Ni; Li-Xin Zhou; Yan-Ping Wei; Ming-Li Li; Wei-Hai Xu; Shan Gao; Li-Ying Cui
Journal:  Ann Transl Med       Date:  2014-08

3.  Severe Cerebral Vasospasm in Patients with Hyperthyroidism.

Authors:  Hyuk-Jin Oh; Seok-Mann Yoon; Jae-Sang Oh; Jai-Joon Shim; Hack-Gun Bae
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-12-31

Review 4.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

5.  Recurrent transient ischemic attacks in a moyamoya syndrome patient with ultra-long imaging follow-up.

Authors:  Lan Zhang; Wei Xing; Jiajia Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 6.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

7.  Immune response profiling identifies autoantibodies specific to Moyamoya patients.

Authors:  Tara K Sigdel; Lorelei D Shoemaker; Rong Chen; Li Li; Atul J Butte; Minnie M Sarwal; Gary K Steinberg
Journal:  Orphanet J Rare Dis       Date:  2013-03-21       Impact factor: 4.123

8.  Variant angina in moyamoya disease--a correlative etiology and different presentation: a case report.

Authors:  Woong Choi; Yu Na Kim; Kyung-Hee Kim
Journal:  J Med Case Rep       Date:  2015-04-22

Review 9.  Diagnosis of moyamoya disease: international standard and regional differences.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 10.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.